New patent expiration for Astrazeneca drug DALIRESP
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It […]
New patent expiration for Astrazeneca drug DALIRESP Read Post »
Patent Expiration
New patent expiration for Takeda Pharms drug ULORIC
Annual Drug Patent Expirations for ULORIC Uloric is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug ULORIC Read Post »
New patent expiration for Alnylam Pharms drug GIVLAARI
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
New patent expiration for Evofem Inc drug PHEXXI
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA.
New patent expiration for Evofem Inc drug PHEXXI Read Post »
New patent expiration for Abbvie drug ALPHAGAN P
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Abbvie and is included in two NDAs.
New patent expiration for Abbvie drug ALPHAGAN P Read Post »
New patent expiration for Leo Pharma drug FINACEA
Annual Drug Patent Expirations for FINACEA Finacea is a drug marketed by Leo Pharma As and is included in two
New patent expiration for Leo Pharma drug FINACEA Read Post »
New patent expiration for Mylan Speciality drug DYMISTA
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one
New patent expiration for Mylan Speciality drug DYMISTA Read Post »
Drug Patent Expirations for the Week of February 25, 2024
DYMISTA (azelastine hydrochloride; fluticasone propionate) Mylan speciality lp Patent: 8,163,723 Expiration: Feb 29, 2024 See More … For more information
Drug Patent Expirations for the Week of February 25, 2024 Read Post »
New patent expiration for Endo Pharms drug NASCOBAL
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
